GlassScriptPhysician profile
Kapil D Sethi
NPI 1003927054
$52,067.78
in general payments reported to CMS, 2019-2025
6 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $35K · 2020: $3,000 · 2021: $14K.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $27,675.00 | 2019 | |
| Neurocrine Biosciences, INC. | $24,211.42 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $103.09 | 2019 | |
| Allergan, INC. | $39.20 | 2019 | |
| Acorda Therapeutics, INC | $39.07 | 2019 |
1 company reported research payments only; those appear in the research section below.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kapil Sethi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.